Achyut Healthcare Limited has achieved a significant corporate milestone by receiving approval from BSE Limited for the migration of its equity shares from the BSE SME platform to the BSE Main Board Platform. This development marks an important step in the company's evolution and provides enhanced market access for investors.

Migration Approval Details

The pharmaceutical company received the formal approval through BSE Limited's communication dated January 01, 2026. The approval process was completed under the regulatory framework governing platform migrations for listed companies.

Trading Commencement

The company's equity shares will be effectively listed and traded on the BSE Main Board Platform starting from Friday, January 02, 2026. This transition represents the culmination of the migration process and provides investors with access to the company's shares on the main board platform.

Regulatory Compliance

Achyut Healthcare Limited has fulfilled all regulatory requirements for the migration process. The company communicated this development to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring full compliance with disclosure obligations.

Company Background

Achyut Healthcare Limited, formerly known as Achyut Healthcare Private Limited, operates in the pharmaceutical sector. The company maintains its registered office in Ahmedabad, Gujarat, with additional corporate and administrative facilities in the region. The migration to the main board platform represents a significant advancement in the company's market presence and accessibility to a broader investor base.

Achyut Healthcare Limited , a pharmaceutical company listed on the Bombay Stock Exchange, has reported promoter shareholding increases through official SEBI disclosures. Akshit M. Raychahuf, belonging to the promoter group, has systematically increased his stake through multiple open market transactions spanning from November to December.

November SEBI Disclosure Details

The company filed disclosures under SEBI Regulation 29(2) of Substantial Acquisition of Shares and Takeovers Regulations, 2011, for transactions conducted in November:

Progressive Shareholding Pattern

The November transactions resulted in a gradual increase in Raychahuf's ownership stake:

December Acquisition Activity

Following the November transactions, Raychahuf continued his acquisition activity in December with additional purchases:

Company Share Capital Structure

Achyut Healthcare Limited's equity structure as disclosed in the filings:

Acquisition Timeline Summary

The complete acquisition pattern demonstrates sustained promoter interest over a two-month period:

All disclosures were filed by Raychahuf from his registered address in Ahmedabad with the BSE Limited's Listing Compliance Department. These systematic transactions demonstrate continued promoter confidence in the pharmaceutical company's prospects and strict adherence to SEBI's substantial acquisition disclosure requirements for listed companies.